Talking Points and FAQs: Cases of Paxlovid Rebound (English, Spanish)

Talking Points and FAQs: Cases of Paxlovid Rebound (English, Spanish)

Date posted: June 7, 2022
Last reviewed: September 12, 2022

The Public Good Projects in collaboration with the Hispanic Communications Network

Talking points and FAQs discuss reports of COVID rebound among people who have taken the COVID-19 treatment, Paxlovid. Some people have reported recovering from COVID-19 after taking Paxlovid but testing positive again two to eight days later and are classified as "rebound" cases. They may or may not have symptoms. The talking points emphasize that the Centers for Disease Control and Prevention continue to recommend Paxlovid for people at high risk of developing severe illness and encourage people who experience a rebound case to re-isolate for at least 5 days. The FAQs cover similar information. A related graphic is available here: Social Media: Graphic on What To Do If You Experience Paxlovid Rebound (English, Spanish).

Report

Automatic translation disclaimer

El sitio web Vaccine Resource Hub proporciona una traducción automática de vaccineresourcehub.org al español, por medio del Traductor de Google. Por favor, tenga en cuenta que la versión en inglés es considerada la más precisa. En caso de desacuerdo o discrepancia entre la traducción y la versión original en inglés de este sitio web o cualquier aviso o descargo, prevalecerá la versión original.